|
|
Aberrant cortical entrainment in biomarker-confirmed Alzheimers disease and mild cognitive impairment |
| 1F30AG076259-01 |
|
NIA |
2022 |
|
|
Explaining racial and ethnic Alzheimer’s disease disparities with joint estimation of life course social inequities and measurement bias in verbal memory assessment |
| 1F31AG076284-01 |
|
NIA |
2022 |
|
|
Sex differences in the genetic etiology of cognitive resilience to Alzheimers disease |
| 1F31AG077791-01 |
|
NIA |
2022 |
|
|
Characterizing vigilance in fMRI data and its relation to age-related cognitive impairment. |
| 1F99AG079810-01 |
|
NIA |
2022 |
|
|
Integrated multi-omics approach to identify early protein biomarkers in Alzheimers disease and cognitive decline |
| 1K01AG071689-01A1 |
|
NIA |
2022 |
|
|
Writing to Heal: Developing an Internet-Based Cognitive-Behavioral Writing Intervention for Alzheimer’s Disease Spousal Caregivers |
| 1K01AG073824-01A1 |
|
NIA |
2022 |
|
|
Characterizing Alzheimers Risk in Retired Night Shift Workers: Cognitive Function, Brain Volume, and Brain Bioenergetics |
| 1K01AG075171-01 |
|
NIA |
2022 |
|
|
Biomarkers of Inflammation, Neurodegeneration and Age-Associated Cognitive Impairment |
| 1K01AG078407-01 |
|
NIA |
2022 |
|
|
Implementation Strategies to Promote Advance Care Planning among Persons Living with ADRD and those with Mild Cognitive Impairment in Outpatient Primary Care Practices |
| 1K23AG070234-01A1 |
|
NIA |
2022 |
|
|
Intraindividual Cognitive Variability as an Early Marker of Alzheimers Disease |
| 1K23AG076663-01 |
|
NIA |
2022 |
